Close Menu

NEW YORK – The National Institutes of Health has renewed funding for the Antibacterial Resistance Leadership Group (ARLG) with up to $102.5 million over seven years.

The grant starts with $15 million in 2020, awarded by the National Institute for Allergy and Infectious Disease (NIAID) to coprincipal investigators Vance Fowler of Duke University and Henry Chambers of the University of California, San Francisco.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.